Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

607
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
607
Cancer Vaccines01:30

Cancer Vaccines

603
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
603
Vaccinations01:51

Vaccinations

48.7K
Overview
48.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same author

Targeting and traceability of DY635-functionalized lipids for cholesterol-free, hepatocyte-directed lipid nanoparticles.

International journal of pharmaceutics·2026
Same author

Novel Cu(II)-complex loaded Eudragit® nanoparticles: design, synthesis, characterization, and enhanced antitumor activity against triple-negative breast cancer.

International journal of pharmaceutics·2026
Same author

Clinical spectrum and management outcomes of acute febrile illness Among children attending health facilities in northwestern Tanzania, 2020-2021.

Frontiers in pediatrics·2026
Same author

Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma.

Leukemia·2026
Same author

Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same journal

Correction: Fukushima et al. Long-Term Immunogenicity of Rabies Pre-Exposure Prophylaxis in Japanese Adult Travelers: Comparison of Dosing Regimens. <i>Vaccines</i> 2025, <i>13</i>, 1169.

Vaccines·2026
Same journal

Access to Vaccines Among Asylum Seekers, Refugees, and Undocumented Migrants Across the Migratory Cycle in the European Union, European Economic Area, Switzerland and the United Kingdom: A Scoping Review.

Vaccines·2026
Same journal

Advances in Detection Methods for Human Respiratory Syncytial Virus Neutralizing Antibodies.

Vaccines·2026
Same journal

Insights from 25 Years of Measles and Measles-Rubella Vaccination Campaigns in the WHO African Region (2001-2025).

Vaccines·2026
Same journal

Post-Marketing Safety Surveillance of Influenza Vaccines in Anhui Province, China, 2016-2025.

Vaccines·2026
Same journal

Characteristics of Hypotonic-Hyporesponsive Episodes (HHEs) Following Childhood Vaccination: A 13-Year Analysis of Spontaneous Reports to the Dutch Pharmacovigilance Centre Lareb.

Vaccines·2026
See all related articles

Related Experiment Video

Updated: Nov 7, 2025

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.8K

mRNA-Based Vaccines.

Frank Kowalzik1, Daniel Schreiner1, Christian Jensen1

  • 1Pediatric Department, University Medical Center of the Johannes Gutenberg-University, 55128 Mainz, Germany.

Vaccines
|April 30, 2021
PubMed
Summary
This summary is machine-generated.

Messenger RNA (mRNA) vaccines offer a rapid, scalable, and cost-effective solution for developing new vaccines against emerging pathogens. Their advantages include safety, broad immunity, and efficient production for global health challenges.

Keywords:
cancerdelivery systemsinfectious diseaselipid nanoparticlesmRNAvaccine constructs

More Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.1K
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.2K

Related Experiment Videos

Last Updated: Nov 7, 2025

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.8K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.1K
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.2K

Area of Science:

  • Biotechnology
  • Immunology
  • Public Health

Background:

  • Increasing global population density accelerates pathogen spread.
  • Traditional vaccine development is insufficient for emerging infectious diseases.
  • Novel vaccine technologies are crucial for global health security.

Purpose of the Study:

  • To review messenger RNA (mRNA) vaccine technology.
  • To discuss factors for effective mRNA vaccine production and delivery.
  • To explore clinical applications of mRNA vaccines.

Main Methods:

  • Review of existing literature on mRNA vaccine platforms.
  • Analysis of factors influencing mRNA transcript and delivery system optimization.
  • Discussion of clinical trial data and outcomes.

Main Results:

  • mRNA vaccines present advantages over conventional vaccines: no infectious elements, genomic integration risk, or host cell genome risk.
  • They induce both humoral and cell-mediated immunity.
  • mRNA vaccines are well-tolerated, cost-effective, and rapidly produced, enabling scalable responses to outbreaks.
  • Demonstrated efficacy in preventing infectious diseases and treating cancers in human and animal models.

Conclusions:

  • mRNA vaccine technology is a promising platform for rapid, large-scale vaccine development.
  • Optimization of production and delivery systems is key to maximizing efficacy.
  • mRNA vaccines hold significant potential for infectious disease prevention and cancer therapy.